Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus

Radiopharm Theranostics

09/01/2025 23:47

** Radiopharm Theranostics  RAD.AX  leaps as much as 50% to
A$0.036; set for biggest ever intraday pct gain
    ** Biopharma secures private placement agreement with
Massachusetts-based Lantheus Holdings  LNTH.O  to raise $5 mln
    ** Issue price of A$0.060 represents 150% premium to last
close
    ** Co earlier signed co-development deal with the
NASDAQ-listed firm to develop biopharmaceuticals in Australia
    ** Stock hits its highest level since Dec. 10, 2024
    ** More than 12.9 mln shares traded, 1.2x the 30-day avg
    ** RAD fell 67.6% in 2024 - third consecutive bear run since
2022

 (Reporting by Kumar Tanishk in Bengaluru)
 ((Tanishk.Kumar@thomsonreuters.com;))